Charles Pitman

Stock Analyst

(n/a)

# 4,648

Out of 4,648 analysts

3

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - General

Stocks Rated by Charles Pitman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ARGX argenx SE	Upgrades: Overweight	n/a	$595.58	-	2	Aug 6, 2024
	ABBV AbbVie	Initiates: Buy	n/a	$203.55	-	1	Jan 13, 2022

argenx SE

Aug 6, 2024

Upgrades: Overweight

Price Target: n/a

Current: $595.58

Upside: -

AbbVie

Jan 13, 2022

Initiates: Buy

Price Target: n/a

Current: $203.55

Upside: -